Comparison of GeneXpert Results of Adult Pulmonary Tuberculosis (TB) Patients with Human Immunodeficiency Virus (HIV) without HIV Infection at three private hospitals in Jakarta
Abstract
Background: Tuberculosis (TB) is a bacterial infection caused by Mycobacterium TB. According to the International Standard for TB Care (ISTC), Human Immunodeficiency Virus (HIV) is one of the main comorbidities in TB. Purposes: To compare the positivity rate of GeneXpert in diagnosing TB to suspected TB adult patients with and without HIV infection at three private hospitals in Jakarta. Methods: This study uses a cross-sectional approach; the data comes from medical records. The sampling technique in this research uses the cluster sampling formula. The inclusion criteria in this study were adult pulmonary TB patients more than 18 years of age, patients with pulmonary TB, and patients who had complete medical record data, and the exclusion criteria were patients who did not have GeneXpert examination results and adult pulmonary TB patients who did not have laboratory results of HIV Rapid test results. Statistical analysis using the Chi-Square statistical test. Results: A total of 24 adult pulmonary TB patients with HIV and positive GeneXpert were identified, whereas 13 adult TB patients with HIV and positive GeneXpert were identified, and pulmonary TB patients without HIV and positive GeneXpert numbered 59, while those with positive GeneXpert numbered 15. There is a tendency for fewer positive GeneXpert values in Adult Pulmonary TB patients with HIV compared to those without HIV Infection. Statistically not significant (p >0.05) Conclusion: Adult pulmonary TB patients without HIV tend to have higher positive GeneXpert test results than adult pulmonary TB patients with HIV, and there is no statistically significant relationship.
Keywords
Full Text:
PDFReferences
Perhimpunan Dokter Paru Indonesia. Tuberkulosis Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Perhimpunan Dokter Paru Indonesia. 2021;1: 1–78.
World Health Organizations. Global Tuberculosis report. 2022. Available from: http://apps.who.int/bookorders
Meintjes G, Brust JCM, Nuttall J, Maartens G. Management of active tuberculosis in adults with HIV. lancet HIV. 2019 Jul;6(7):e463–74.
Fachri M, Fauzi RA, Akaputra R. Gambaran Radiologi Foto Toraks Pasien TB Paru Resistan Obat dengan dan Tanpa DM Tipe 2 di Rumah Sakit Islam Jakarta Sukapura. J Kedokt dan Kesehat. 2021;17(2):177.
Utami PR, Amelia N, Susanto V, Adfar TD. Pemeriksaan GeneXpert Terhadap Tingkat Positivitas Pemeriksaan Basil Tahan Asam (BTA) Metode Ziehl Neelsen Pada Penderita Suspek TB Paru. J Kesehat PERINTIS (Perintis’s Heal Journal). 2021;8(1):82–90.
Camila F. Hubungan Kondisi Lingkungan Rumah dengan Kejadian Tuberkulosis di Wilayah Kerja Puskesmas Tamansari Kota Tasikmalaya Tahun 2022. Universitas Siliwangi; 2022.
Wikanningtyas TA, Hatta M, Massi MN, Pratiwi I, Fachri M, Bahrun U, et al. Hematologic parameters in pulmonary tuberculosis patients based on the microscopic sputum examination. Enfermería Clínica [Internet]. 2020;30:243–6. Available from: https://www.elsevier.es/es-revista-enfermeria-clinica-35-articulo-hematologic-parameters-in-pulmonary-tuberculosis-S1130862119304541
Baedowi A, Zulfian, Rusmini H, Prasetia T. Hubungan Jumlah Viral Load dengan Kejadian TBC pada Pasien HIV/AIDS yang Mendapatkan Terapi ARV. Arter J Ilmu Kesehat. 2020 May 30;1(3 SE-Articles).
Sihotang RH, Benny S. Lampus, Pandelaki AJ. Gambaran Penderita Tuberkulosis Paru yang Berobat Menggunakan DOTS di Puskesmas Bahu Malalayang I Periode Januari-Desember 2012. J Kedokt Komunitas dan Trop. 2013;1(1):69–72.
Teferi MY, Didana LD, Hailu T, Woldesenbet SG, Bekele S, Mihret A. Tuberculosis treatment outcome and associated factors among tuberculosis patients at Wolayta Sodo Teaching and Referral Hospital, Southern Ethiopia: a retrospective study. J Public health Res. 2021 Apr;10(3).
Munir SM, Nawas A, Soetoyo DK. Pengamatan Pasien Tuberkulosis Paru dengan Multidrug Resistant (TB-MDR) di Poliklinik Paru RSUP Persahabatan. J Respirologi Indones. 2010;30(2):1 of 13.
Caceres N de A, Vieira MMC, Vieira IF, Monteleone VF, Neto LJM, Bonafe S. Opportunistic infections in AIDS. Aust J Med Sci. 1996;17(4):159–60.
Fadhilah NA, Muflihah H, Maharani W. Kesepakatan Hasil Pemeriksaan Tes Cepat Molekuler (TCM) dengan Pemeriksaan Mikroskopik Basil Tahan Asam (BTA) dalam Penegakkan Diagnosis Tuberkulosis Paru. Bandung Conf Ser Med Sci. 2023;3(1):1013–20.
Guenaoui K, Harir N, Ouardi A, Zeggai S, Sellam F, Bekri F, et al. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases. Ann Transl Med. 2016 May;4(9):168.
Trivedi SS, Desai SG. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle. 1988 Mar;69(1):37–42.
Shah AR, Agarwal SK, Shah K V. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Int J Tuberc lung Dis Off J Int Union against Tuberc Lung Dis. 2002 Dec;6(12):1098–101.
Chowgule R V, Deodhar L. Pattern of secondary acquired drug resistance to antituberculosis drug in Mumbai, India--1991-1995. Indian J Chest Dis Allied Sci. 1998;40(1):23–31.
Rasaki S, jibola A, Musa S, Moradeyo A, Odeigah L, Abdullateef S, et al. Rifampicin Resistant Tuberculosis in a Secondary Health Institution in Nigeria, West Africa. J Infect Dis Ther. 2014 Apr 26;2:1–5.
Olusoji D, Osman E, Oladimeji O, Dairo O. Pre-extensive drug resistant tuberculosis (Pre-XDR-TB) among MDR-TB patents in Nigeria. Glob Adv Res J Microbiol. 2013 Feb 11;2.
Lawson L, Habib AG, Okobi MI, Idiong D, Olajide I, Emenyonu N, et al. Pilot study on multidrug resistant tuberculosis in Nigeria. Ann Afr Med. 2010;9(3):184–7.
Ganguly J, Ray S, Nandi S, Halder S, Kundu S, Mandal A. A study to evaluate pattern of rifampicin resistance in cases of sputum positive pulmonary tuberculosis. J Evol Med Dent Sci. 2015 Apr 3;4:4762–8.
Idigbe O, Sofola T, Akinosho R, Onwujekwe D, Odiah F, Okoye R. Initial drug resistance tuberculosis amongst HIV seropositive and seronegative prison inmates in Lagos, Nigeria. In: Int Conf AIDS. 1998. p. 137.
Otu A, Umoh V, Habib A, Ameh S, Lawson L, Ansa V. Drug resistance among pulmonary tuberculosis patients in Calabar, Nigeria. Pulm Med. 2013;2013.
Suriani Simarmata O, Bisara Lolong D, UpayaKesehatan Masyarakat P, Litbangkes B. Pemanfaatan Tes Cepat Molekuler (TCM) Genexpert Sebagai Alat Diagnostik TB Paru di RSUD Wangaya Kota Denpasar. 2020;135–48.
Widiastuti EN, Subronto YW, Promono D. Faktor risiko kejadian multi drug resistant tuberculosis di RSUP Dr. Sardjito. Ber Kedokt Masy. 2017;33(7):325.
Bhadke BB, Rathod RK, Mulay SD, Deshmukh DG, Mahajan PD. Efficacy of genexpert in diagnosing MTB / RIF resistance in HIV seropositive and seronegative patients: a study in comparison. Int J Med Microbiol Trop Dis. 2017;3(2):50.
Fachri M, Hatta M, Abadi S, Santoso SS, Wikanningtyas TA, Syarifuddin A, et al. Comparison of acid fast bacilli (AFB) smear for Mycobacterium tuberculosis on adult pulmonary tuberculosis (TB) patients with type 2 diabetes mellitus (DM) and without type 2 DM. Vol. 23, Respiratory medicine case reports. England; 2018. p. 158–62.
Hendewi A, Lubis H. Hubungan Koinfeksi Tuberkulosis dan Human Immunodeficiency Virus (HIV) Serta Kaitannya dengan Multi Drug Resistant Tuberculosis (MDR-TB) di Kota Medan Tahun 2019. J Ilm Kohesi. 2021 Jul 19;5(3 SE-Articles).
DOI: https://doi.org/10.24853/mmj.5.2.89-96
Refbacks
- There are currently no refbacks.
Indexed by:
13.jpg)
Work is distributed under the Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of Muhammadiyah Medical Journal (e issn: 2721-317X)